JPMorgan Chase & Co’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,052
| Closed | -$56.9K | – | 6813 |
|
|
2023
Q4 | $56.9K | Buy |
14,052
+911
| +7% | +$3.69K | ﹤0.01% | 4976 |
|
|
2023
Q3 | $35.3K | Sell |
13,141
-2,572
| -16% | -$6.92K | ﹤0.01% | 5005 |
|
|
2023
Q2 | $147K | Buy |
15,713
+2,676
| +21% | +$25K | ﹤0.01% | 4451 |
|
|
2023
Q1 | $116K | Buy |
13,037
+3,398
| +35% | +$30.2K | ﹤0.01% | 4585 |
|
|
2022
Q4 | $48K | Buy |
9,639
+480
| +5% | +$2.39K | ﹤0.01% | 4754 |
|
|
2022
Q3 | $53K | Buy |
9,159
+75
| +0.8% | +$434 | ﹤0.01% | 4691 |
|
|
2022
Q2 | $50K | Buy |
9,084
+3,687
| +68% | +$20.3K | ﹤0.01% | 4851 |
|
|
2022
Q1 | $62K | Buy |
5,397
+289
| +6% | +$3.32K | ﹤0.01% | 4933 |
|
|
2021
Q4 | $65K | Buy |
+5,108
| New | +$65K | ﹤0.01% | 4987 |
|